On Friday, the S&P/ASX 200 index climbed by 0.3% to close at 8,774, partially recovering from losses experienced the day before. This upturn was largely driven by market speculation around a more accommodating domestic monetary policy. A job report for August revealed an unexpected decline in employment, which bolstered expectations for a rate cut by the Reserve Bank of Australia (RBA) later in the year. Although most analysts forecast that interest rates will remain stable in September, they anticipate a possible reduction in November contingent on the upcoming third-quarter inflation data slated for release in October. The RBA has suggested it prefers to assess quarterly data over monthly figures, which it deems less dependable, as it decides the pace for monetary easing. Investors are also keenly awaiting next week's PMI figures to further assess the nation's economic condition.
In corporate developments, Telix Pharmaceuticals saw a significant 6.4% surge, spearheading gains in the healthcare sector after Citi began coverage of the stock with a "Buy" recommendation. Furthermore, technology stocks advanced by 0.9%, following record highs on Wall Street, while financial stocks, sensitive to interest rate changes, rose by 0.6%. The Commonwealth Bank of Australia, the country's leading lender, posted a gain of 1.5%.
